Medicine composition for treating chronic nephrosis and preparation method thereof

A technology for chronic kidney disease and composition, applied in the field of medicine and medicine, can solve problems such as long course of treatment, and achieve the effects of short course of treatment, fast onset of action, and reasonable compatibility

Inactive Publication Date: 2016-02-17
崔玉美
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the course of treatment is long. In order to strengthen the therapeutic effect, now on the basis of traditional Chinese medicine combined with western medicine, a compound preparation is made, which greatly improves the curative effect of traditional Chinese medicine and reduces the side effects of western medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A pharmaceutical composition for treating chronic kidney disease, characterized in that: it is prepared from the following raw materials in parts by weight: 30 parts of emblica, 30 parts of frangipani, 30 parts of fern, 20 parts of hollyhock, 20 parts of Ligusticum edulis, 20 parts of Polyporus, 5 parts of Yellow Hollyhock, 5 parts of Pangui, 5 parts of Red Back Vegetable, 5 parts of August Zha, 5 parts of Jiazhu, 3 parts of Epimedium, 3 parts of Ziheche, 3 parts Akebia, 3 parts Radix, 3 parts Astragalus, 3 parts Perrin, 3 parts Plantago, 3 parts Pseudophysalis, 3 parts Aesculus, 3 parts Hedyotis diffusa, 3 parts Acanthus , 3 parts of Sangjisheng, 3 parts of psoralen, 3 parts of Guangui, 3 parts of saponin, 3 parts of hemophilus, 3 parts of June snow, 3 parts of Dannanxing, 3 parts of knotweed, 3 parts of Patrinia, 3 parts of Part Smilax; 1 part diclofenac sodium, 0.5 part dextran, 0.1 part casein phosphopeptide, 0.1 part povidone, 0.1 part menthol, 0.1 part vitamin D, ...

Embodiment 2

[0056]A pharmaceutical composition for treating chronic kidney disease, characterized in that: it is prepared from the following raw materials in parts by weight: 40 parts of emblica, 40 parts of frangipani, 40 parts of phoenix, 25 parts of hollyhock, 25 parts of Ligusticum edulis, 25 parts of Polyporus, 7.5 parts of hollyhock, 7.5 parts of Pangui, 7.5 parts of red cabbage, 7.5 parts of August Zha, 7.5 parts of Jiazhu, 4 parts of Epimedium, 4 parts of Ziheche, 4 parts Akebia, 4 parts Radix, 4 parts Astragalus, 4 parts Perrin, 4 parts Plantago, 4 parts Pseudophysalis, 4 parts Aesculus, 4 parts Hedyotis diffusa, 4 parts Acanthus , 4 parts of Sangjisheng, 4 parts of psoralen, 4 parts of Guangui, 4 parts of saponin, 4 parts of hemophilus, 4 parts of Junexue, 4 parts of Dannanxing, 4 parts of knotweed, 4 parts of Patrinia, 4 parts of 1 part smilax; 2 parts diclofenac sodium, 0.75 parts dextran, 0.15 parts casein phosphopeptide, 0.15 parts povidone, 0.15 parts menthol, 0.15 parts vi...

Embodiment 3

[0080] A pharmaceutical composition for treating chronic kidney disease, characterized in that: it is prepared from the following raw materials in parts by weight: 50 parts of emblica, 50 parts of frangipani, 50 parts of fern, 30 parts of hollyhock, 30 parts of Ligusticum edulis, 30 parts of Polyporus, 10 parts of Yellow Hollyhock, 10 parts of Pangui, 10 parts of Red Back Vegetable, 10 parts of August Zha, 10 parts of Jiazhu, 5 parts of Epimedium, 5 parts of Ziheche, 5 parts Akebia, 5 parts Radix, 5 parts Astragalus, 5 parts Perrin, 5 parts Plantago, 5 parts Pseudophysalis, 5 parts Aesculus, 5 parts Hedyotis diffusa, 5 parts Acanthus , 5 parts of Sangjisheng, 5 parts of psoralen, 5 parts of Guangui, 5 parts of saponin, 5 parts of hemophilus, 5 parts of June snow, 5 parts of Dannanxing, 5 parts of knotweed, 5 parts of Patrinia, 5 parts of Parts of Smilax; 3 parts of diclofenac sodium, 1 part of dextran, 0.2 part of casein phosphopeptide, 0.2 part of povidone, 0.2 part of mentho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating chronic nephrosis. The medicine composition is characterized by being prepared from, by weight, emblic leafflower fruits, jasminum grandiflorum, Chinese brake herb, abelmoschus manihot, ligusticum, grifola, abelmoschus manihot, persicaria perfoliata, all-grass of twocolor velvetplant, fiveleaf akebia fruits, pangolin scales, herba epimedii, human placenta, clematis chrysocoma, radish seeds, milkvetch roots, herba eupatorii, semen plantaginis, fruits or seeds of Apple of Peru, paris polyphylla, oldenlandia diffusa, justicia procumbens, loranthus parasiticus, fructus psoraleae, Chinese cinnamon, melanterite, centella asiatica, serissa japonica, arisaema cum bile, giant knot weed, field pennycress, chinaroot greenbrier, diclofenac sodium, dextran, casein phosphopeptides, povidone, menthol, Vitamin D, pantothenic acid, citric acid, Vitamin E, Vitamin K and cellulose. The medicine composition has the effects of clearing away heat and toxic materials, inducing diuresis to reduce edema and warming kidney and excreting dampness.

Description

technical field [0001] The invention relates to the field of medical medicine, in particular to a pharmaceutical composition for treating chronic kidney disease and a preparation method. Background technique [0002] Chronic kidney disease deeply troubles patients. The incidence of chronic kidney disease is characterized by "three highs" and "three lows": high incidence, high prevalence of associated cardiovascular disease, and high mortality; low awareness rate of chronic kidney disease in the whole society, low prevention and treatment rate, and associated The awareness rate of cardiovascular disease is low. Surveys show that the prevalence of chronic kidney disease among people over 40 years old in my country is greater than 10%, but the awareness rate is less than 5%. In my country, the most chronic kidney disease patients occur in glomerulonephritis, accounting for 40%. With the changes in the dietary structure and living habits of the Chinese population, other secon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/48A61K38/17A61P13/12A61K31/194A61K31/197A61K31/196A61K31/355A61K31/59A61K31/717A61K31/721A61K31/79A61K33/26A61K35/36A61K35/50A61K36/90A61K36/896A61K38/44A61K38/47
CPCA61K36/47A61K31/045A61K31/194A61K31/196A61K31/197A61K31/355A61K31/59A61K31/717A61K31/721A61K31/79A61K33/26A61K35/36A61K35/50A61K36/07A61K36/11A61K36/185A61K36/19A61K36/23A61K36/236A61K36/28A61K36/282A61K36/296A61K36/31A61K36/41A61K36/481A61K36/487A61K36/54A61K36/63A61K36/68A61K36/704A61K36/716A61K36/74A61K36/748A61K36/81A61K36/8884A61K36/896A61K36/90A61K38/17A61K38/446A61K38/47A61K38/484A61K2236/15A61K2236/19A61K2236/331A61K2236/51A61K2236/53A61K2236/55C12Y115/01001C12Y302/01003C12Y304/21007A61K2300/00
Inventor 崔玉美
Owner 崔玉美
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap